Possible solutions to the problems of clinical heterogeneity of outcome measures and inadequate reporting of results for randomized controlled trials (RCTs) on carpal tunnel syndrome (CTS) are presented. Meta-analysis was impeded by these problems in 2 systematic reviews concerning conservative and surgical treatment options for CTS. A solution to the problem of inadequate data presentation is to add explicit information on minimal requirements with regard to data presentation to guidelines for the reporting of studies. To resolve the problem of clinical heterogeneity of the outcomes there should be consensus on the (validated) outcomes that should be used in RCTs. For CTS there is little evidence available on the reliability, validity, and responsiveness to change of the commonly used outcomes in RCTs.
important part of a systematic review. Meta-analysis is only feasible if RCTs are clinically homogeneous, that is, if the patients, interventions, comparisons, outcomes, and timing of follow-up measurements are sufficiently similar. 2 Randomized controlled trials, however, may use a range of different outcome measures. 3'4 Another prerequisite for combining study results is adequate and uniform data presentation. Reporting of results in biomedical journals is often inadequate. 5"6 This article presents possible solutions to the problems of clinical heterogeneity of the outcome measures and inadequate reporting of results for RCTs on carpal tunnel syndrome (CTS). First we show, however, that meta-analysis was impeded by these problems in 2 systematic reviews concerning conservative and surgical treatment options for CTS. 7'~
Methods

Systematic Reviews
To identify publications, a search was performed with Medline (January 1966-March 2000), Embase (January 1988 -February 2000 , and the Cochrane Controlled Trials Register (2000, issue 1), together with reference checking. A generic search for RCTs 9 was combined with a specific search for CTS (by using the key words carpal tunnel syndrome, carpal tunnel, carpal syndrome, and tunnel syndrome). To be included, a study had to meet the following criteria: (t) the study population consisted of patients with CTS; (2) the efficacy of one or more conservative treatment options was evaluated or different surgical techniques were compared; (3) the study was designed as an RCT; and (4) the results were published as a full report, written in Dutch, English, French, or German. Studies were selected by 2 reviewers independently and disagreements were discussed to reach a consensus.
Data from the articles were extracted independently by 2 reviewers and recorded on a standardized form. Discrepancies were identified and resolved after discussion. Information was collected on patients, interventions, outcomes, timing of follow-up measurements, and results. Outcome measures were considered to be clinically homogeneous if the definitions and measurement scales were sufficiently similar in the opinion of the reviewers. Reporting of the results was considered to be adequate if any of the following data were presented for each treatment group, next to the number of patients per group: the mean and SD; the median and (interquartile) range of the outcome measure (continuous outcomes); the number of patients with the outcome of interest (dichotomous outcomes); and the frequency distribution of the outcome measure (ordinal outcomes). The feasibility of combining individual study results was investigated based on both the similarity of outcome measures and adequacy of reporting of the results.
Results
Regarding the conservative treatment options there were 2 studies available for each of the following contrasts of interventions: steroid injections versus placebo, ~ 0,~ ~ ultrasound versus placebo, 12,~ 3 pyridoxine versus placebo,~4' 15 diuretics versus placebo, ~6.~ 7 and oral steroids versus placebo. ~6.18 Of the RCTs on surgical techniques 7 RCTs compared endoscopic carpal tunnel release with open carpal tunnel release (OCTR),19-26 3 RCTs evaluated the effect of OCTR with a new incision technique versus OCTR with a standard incision, 27 3o and 3 RCTs compared OCTR with additional internal neurolysis with OCTR alone. [31] [32] [33] [34] Data presentation in the RCTs concerning conservative treatment options for CTS was generally adequate. The most commonly used outcome measures were those related to symptoms of CTS. A wide variety of those measures were used including the following: specific descriptions of symptoms (eg, pain, paraesthesias), 11"~3 more general expressions (eg, night discomfort or just symptoms),m'14 combinations of symptoms (eg, night/day pain/paraesthesias, global symptom score), J3.~6.~8 measures relating to improvement of symptoms (eg, symptoms improved/changed/worsened), 15 or severity of symptoms (eg, main complaints: no complaints at all [0] to the most intense complaints I can imagine [10] ). ~2 Because pooling of heterogeneous outcomes will lead to an uninterpretable and misleading pooled estimate, meta-analysis is not feasible. Only the 2 trials concerning the efficacy of oral steroids ~6"~8 used the same outcome measure, but unfortunately only one 16 adequately reported means and SDs. Two of the other outcome measures (distal motor latency and distal sensory latency) were considered to be sufficiently similar, but this was only a very small subset of all outcomes used and in our opinion not the most important ones. In general, pooling of a subset of outcome measures may be misleading.
The RCTs concerning surgical treatment options for CTS also used many different types of outcomes related to symptoms, but the other commonly used outcome measures (such as grip and pinch strength, manual muscle testing, 2-point discrimination, Semmes-Weinstein monofilament testing, nerve conduction studies, and return to work) were considered to be sufficiently similar. Data presentation, however, was often inadequate and combining individual study results is therefore not possible. Most articles reported both pre-and postoperative data but did not add change scores. In most cases dichotomous data were reported correctly. For continuous data, however, many articles failed to report the standard deviation of the Outcome 23"25'26'28'29"31 and/or the total number of patients in each group. 19"26'27~33"34 Sometimes data had to be estimated from graphs, which is often very inaccurate because of the unclear scales used on the vertical axes. 23"28 3o Furthermore in some studies data for a particular outcome were presented as dichotomous data, whereas in other studies they were presented as continuous data or, for example, as percentage change from baseline. 26'~29
Because pooling of the data was not possible in both systematic reviews on CTS, qualitative analyses were performed instead by using a rating system consisting of 4 levels of evidenceY
Enabling Meta-Analysis
The aim of this article was to present possible solutions to the problems of clinical heterogeneity of the outcome measures and inadequate reporting of results for RCTs on CTS. This will increase the comparability of the RCTs, enabling the calculation of a pooled estimate of effect in a meta-analysis, in addition to estimating the strength of the evidence in a qualitative analysis. Other aspects of clinical homogeneity, that is, similarity of the patients, interventions, comparisons, and timing of follow-up measurements are not addressed.
Outcome Measures
To resolve the problem of clinical heterogeneity of the outcome measures in a particular field of research, for example, CTS research, the outcomes and the instruments used to measure these outcomes should be standardized. In addition to this set of standard outcomes, researchers could add outcome measures of their own choice. A good example of efforts to standardize outcome measures is the Outcome Measures in Rheumatoid Arthritis Clinical Trials project, the mission of which was to develop consensus on a core set of outcomes for rheumatoid arthritis (and other major musculoskeletal conditions). 36 Another recent example is the proposal for standardized use of outcome measures for low back pain research. 37 Also for CTS research and research in other fields efforts should be made to achieve international consensus on the use of outcomes in RCTs, similar to the efforts that resulted in consensus criteria for the classification of CTS in epidemiologic studies. 38 Outcome measures selected for standardized use should be relevant to patient health status and should preferably be validated (ie, evaluated with regard to reliability, validity, and responsiveness to change), otherwise invalid outcomes might be combined, providing a precise estimate of the wrong results. There is little evidence available, however, on the reliability, validity, and responsiveness to change of the commonly used outcome measures in CTS studies and more research is therefore needed. In 1993 a self-administered questionnaire for CTS was introduced, consisting of a scale for the assessment of severity of symptoms and a scale for the assessment of functional status. 39 These scales have been reported to be reproducible, internally consistent, valid, and responsive to clinical change 39'4° and have subsequently been used in several studies. 24"41 '42 Four of the 9 studies on conservative treatment options started including patients after the publication of this questionnaire but unfortunately did not include it as an outcome measure. 9'12"13a6
Reporting of Results
The problem of inadequate reporting of the results can easily be resolved. There clearly has to be a standardized format for the presentation of data that includes the key elements needed for pooling. For dichotomous outcomes the number of patients with the outcome of interest and the total number of patients should be presented for each treatment group to enable calculation of a pooled estimate of effect (eg, odds ratio, risk ratio, or risk difference). For continuous outcomes, the mean and SD of the outcome measure and the total number of patients should be presented for each treatment group to enable calculation of a mean difference or a standardized mean difference (effect size). These values should be presented for both follow-up data and change scores. Presentation of the median and (interquartile) range is appropriate for reporting if the outcome is not normally distributed, but methods to pool these data have not yet been developed.
Many journals have already adopted guidelines for the reporting of studies. Since 1988 the Uniform Requirements for Manuscripts Submitted to Biomedical Journals includes a section on the presentation of statistical aspects. 43 This section is quite brief: "When possible, quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals)," "Give numbers of observations," and "Identify statistical measures of variation such as standard deviation and standard error of the mean." In 1997 these uniform requirements were accepted by more than 500 journals. 44 An important recent example is the Consolidated Standards of Reporting Trials (CONSORT) statement published in 1996. 45 By the end of 1997 this guideline was adopted by more than 70 journals. 46 In these guidelines the section on presentation of the data is rather concise: "State estimated effect of intervention on primary and secondary outcome measures, including a point estimate and measure of precision (confidence interval)," "State results in absolute numbers when feasible (eg, 10/20 not 50%)," and "Present summary data and appropriate descriptive and inferential statistics in sufficient detail to permit alternative analyses and replication."
Most studies included in the systematic review concerning surgical treatment options for CTS were published before the introduction of the CONSORT statement. Moreover, only one of the journals in which these RCTs were published has endorsed the statement (Nederlands Tijdschrift voor Geneeskunde). Some of the other journals have included guidelines on data presentation in their instructions for authors, but none of them states that studies should be reported in accordance with the Uniform Requirements.
A possible solution to the problem of inadequate data presentation would be to add explicit information to a revised CONSORT statement on minimal requirements with regard to data presentation including the key elements needed for pooling. To overcome the problem of inadequate data presentation in a systematic review, additional information could be requested from the researchers of the original studies. This may not be feasible in many reviews, however, because of a lack of time and resources. Furthermore data of trials published at least 5 years previously might no longer be available, or it might be difficult to find the researchers of old trials.
